Special Article: Case Report
CellMed 2023; 13(3): 12.1-12.3
Published online February 28, 2023
https://doi.org/10.5667/CellMed.spc.012
© Cellmed Orthocellular Medicine and Pharmaceutical Association
A case study of a patient with dyslipidemia using Ortho-Cellular Nutrition Therapy (OCNT)
Correspondence to : Geumgang Pharmacy
Objective: A case report on improvement of dyslipidemia by Ortho-Cellular Nutrition Therapy (OCNT). Methods: The patient is a Korean male aged 60 years. His total cholesterol index is in the high-risk group. Results: Symptoms of diabetes and dyslipidemia after nutritional therapy are improved. Conclusion: For people with dyslipidemia, nutritional therapy can help reduce symptoms.
Keywords Ortho-Cellular Nutrition Therapy (OCNT); Dyslipidemia
PDF
Standard view
Export citation
Share Article
Case Report
CellMed 2023; 13(3): 12.1-12.3
Published online February 28, 2023 https://doi.org/10.5667/CellMed.spc.012
Copyright © Cellmed Orthocellular Medicine and Pharmaceutical Association.
A case study of a patient with dyslipidemia using Ortho-Cellular Nutrition Therapy (OCNT)
Sujeong, Shin
Geumgang Pharmacy
Correspondence to:Geumgang Pharmacy
Abstract
Objective: A case report on improvement of dyslipidemia by Ortho-Cellular Nutrition Therapy (OCNT). Methods: The patient is a Korean male aged 60 years. His total cholesterol index is in the high-risk group. Results: Symptoms of diabetes and dyslipidemia after nutritional therapy are improved. Conclusion: For people with dyslipidemia, nutritional therapy can help reduce symptoms.
Keywords: Ortho-Cellular Nutrition Therapy (OCNT), Dyslipidemia
Stats or Metrics
Share this article on
Related articles in CellMed
-
A Case Study on Improving Pressure Ulcers Using Ortho-Cellular Nutrition Therapy (OCNT)
Pharmacist, Ayoung Lee
CellMed 2024; 14(16): 3.1-3.4 -
Improvement of Growth Retardation Using Ortho-Cellular Nutrition Therapy (OCNT)
Pharmacist, Mijin Kim
CellMed 2024; 14(16): 2.1-2.3 -
Improvement in Infertility Through the Application of Ortho-Cellular Nutrition Therapy (OCNT)
Pharmacist, Jong-Bin Jo
CellMed 2024; 14(16): 1.1-1.3
